Focus Financial Network
IMRX icon

Focus Financial Network’s Immuneering IMRX Stock Holding History

Focus Financial Network’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$49.1K Sell
12,000
-500
-4% -$2.36K ﹤0.01% 761
2026
Q2 		$62.4K Buy
+12,500
New +$63.2K ﹤0.01% 762

Other funds holding IMRX

PAM
PVG Asset Management Golden, Colorado $147M AUM 52.72% 1-Year Est. Return
FCC
Flower City Capital Pittsford, New York $234M AUM 15.69% 1-Year Est. Return
Berman McAleer
Berman McAleer Timonium, Maryland $862M AUM 13.92% 1-Year Est. Return
FIA
FNY Investment Advisers New York $402M AUM 85.34% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $163M AUM 15.03% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Focus Financial Network's IMRX Position: Q3 2026 in Review

Focus Financial Network reduced its Immuneering (IMRX) stake by 4% in Q3 2026, selling an estimated $2.36K and leaving 12,000 shares worth $49.1K. The position accounts for ﹤0.01% of the portfolio, ranked #761.

Focus Financial Network first reported a position in IMRX in Q2 2026 and has held it in 2 quarters since. The position peaked at $62.4K in Q2 2026. 10 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.

  • Focus Financial Network held 12,000 shares of Immuneering worth $49.1K as of Q3 2026.
  • Focus Financial Network sold 500 Immuneering shares in Q3 2026, an estimated $2.36K.
  • Immuneering made up ﹤0.01% of Focus Financial Network's portfolio in Q3 2026, its #761 holding.
  • Focus Financial Network first reported a position in Immuneering in Q2 2026 and has held it in 2 quarters since.
  • Focus Financial Network's Immuneering position peaked at $62.4K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.

Based on Focus Financial Network's 13F filing for Q3 2026, filed 14 Oct 2026.